SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

The discovery that diabetes medication could potentially manage hydrocephalus occurred after Dr Magill observed significant ...

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only ...

The American Gastroenterological Association applauded the Supreme Court's Kennedy v. Braidwood decision, which preserves ...

A study found that the newer generation of much more effective diabetes medications are reaching only a fraction of the ...

Israel: A new study published in JAMA Network Open highlights a key safety insight for patients with type 2 diabetes taking ...

With hot summer temperatures setting in, local doctors are warning that heat-related illnesses can escalate quickly — ...

Chronic kidney disease (CKD) represents a major global public health challenge, significantly impacting patients' quality of life and placing a heavy burden on healthcare systems. While diabetes and ...

Subscribe to UCSF NewsA UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of ...

Sodium-glucose cotransporter-2 (SGLT2) inhibitors are a newer type of medication used to help people with diabetes manage ...

The study, published in GeroScience, was led by researchers exploring ways to improve vascular health in older adults.